Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-30
Original SEC Filing: Click here

---

Webplus: SVA/20090930/6-K/2_EX-99.1/000.htm SEC Original: sinovacexh99_1.htm
I. SINOVAC REPORTS UNAUDITED SECOND QUARTER 2009 FINANCIAL RESULTS – Conference call scheduled Wednesday, August 19, 2009 at 8:00 a.m. ET – – Reaffirmation of 2009 sales projection to be $55 million to $60 million – – H1N1 vaccine may drive additional growth – BEIJING, Aug. 19 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider

---

---

Webplus: SVA/20090930/6-K/1/000.htm SEC Original: sinovac6k081909.htm
FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2009-09-30CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085